Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 23% ± 7% | |
epithelial cell | 10 studies | 34% ± 17% | |
naive B cell | 9 studies | 20% ± 3% | |
B cell | 9 studies | 21% ± 6% | |
basal cell | 7 studies | 26% ± 14% | |
ciliated cell | 6 studies | 29% ± 18% | |
memory B cell | 6 studies | 20% ± 2% | |
classical monocyte | 5 studies | 21% ± 2% | |
non-classical monocyte | 4 studies | 25% ± 5% | |
vein endothelial cell | 4 studies | 18% ± 3% | |
goblet cell | 4 studies | 22% ± 4% | |
endothelial cell of vascular tree | 4 studies | 20% ± 5% | |
secretory cell | 4 studies | 38% ± 14% | |
conventional dendritic cell | 3 studies | 22% ± 5% | |
precursor B cell | 3 studies | 23% ± 2% | |
immature B cell | 3 studies | 23% ± 3% | |
endothelial cell of lymphatic vessel | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1162.83 | 966 / 966 | 100% | 27.90 | 527 / 527 |
breast | 100% | 894.06 | 459 / 459 | 100% | 20.22 | 1116 / 1118 |
bladder | 100% | 683.52 | 21 / 21 | 100% | 23.41 | 503 / 504 |
esophagus | 100% | 1076.94 | 1442 / 1445 | 100% | 27.25 | 183 / 183 |
uterus | 100% | 657.01 | 170 / 170 | 100% | 26.19 | 458 / 459 |
lung | 100% | 905.43 | 576 / 578 | 100% | 23.32 | 1155 / 1155 |
ovary | 99% | 467.26 | 179 / 180 | 100% | 17.90 | 430 / 430 |
stomach | 100% | 805.22 | 359 / 359 | 99% | 23.44 | 284 / 286 |
prostate | 100% | 620.43 | 245 / 245 | 99% | 14.05 | 497 / 502 |
thymus | 100% | 611.98 | 651 / 653 | 99% | 14.14 | 598 / 605 |
kidney | 100% | 692.80 | 89 / 89 | 96% | 14.51 | 864 / 901 |
pancreas | 95% | 363.85 | 313 / 328 | 99% | 28.00 | 176 / 178 |
skin | 100% | 1358.30 | 1809 / 1809 | 94% | 13.18 | 444 / 472 |
brain | 96% | 306.90 | 2526 / 2642 | 98% | 9.38 | 688 / 705 |
liver | 100% | 382.34 | 226 / 226 | 81% | 7.69 | 330 / 406 |
adrenal gland | 100% | 756.18 | 258 / 258 | 74% | 6.58 | 171 / 230 |
adipose | 100% | 1010.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.81 | 29 / 29 |
spleen | 100% | 989.44 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.04 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.39 | 1 / 1 |
blood vessel | 99% | 578.01 | 1323 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1092.62 | 902 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 341.64 | 817 / 861 | 0% | 0 | 0 / 0 |
muscle | 56% | 142.54 | 452 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 49% | 3.44 | 39 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042327 | Biological process | positive regulation of phosphorylation |
GO_0002906 | Biological process | negative regulation of mature B cell apoptotic process |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0002224 | Biological process | toll-like receptor signaling pathway |
GO_0050870 | Biological process | positive regulation of T cell activation |
GO_0051260 | Biological process | protein homooligomerization |
GO_0050862 | Biological process | positive regulation of T cell receptor signaling pathway |
GO_0061760 | Biological process | antifungal innate immune response |
GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0012501 | Biological process | programmed cell death |
GO_0001783 | Biological process | B cell apoptotic process |
GO_0045087 | Biological process | innate immune response |
GO_0006968 | Biological process | cellular defense response |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0070231 | Biological process | T cell apoptotic process |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0002250 | Biological process | adaptive immune response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0032765 | Biological process | positive regulation of mast cell cytokine production |
GO_0016064 | Biological process | immunoglobulin mediated immune response |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0001843 | Biological process | neural tube closure |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0038061 | Biological process | non-canonical NF-kappaB signal transduction |
GO_0032094 | Biological process | response to food |
GO_0032761 | Biological process | positive regulation of lymphotoxin A production |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0001772 | Cellular component | immunological synapse |
GO_0002096 | Cellular component | polkadots |
GO_0045121 | Cellular component | membrane raft |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005764 | Cellular component | lysosome |
GO_0032449 | Cellular component | CBM complex |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0005881 | Cellular component | cytoplasmic microtubule |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0050700 | Molecular function | CARD domain binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0002020 | Molecular function | protease binding |
GO_0019209 | Molecular function | kinase activator activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0140296 | Molecular function | general transcription initiation factor binding |
GO_0043422 | Molecular function | protein kinase B binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0051059 | Molecular function | NF-kappaB binding |
Gene name | BCL10 |
Protein name | BCL10 immune signaling adaptor Mutant B-cell CLL/lymphoma 10 B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10) (Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein) (hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator) (CIPER) (Cellular homolog of vCARMEN) (cCARMEN) (Cellular-E10) (c-E10) (Mammalian CARD-containing adapter molecule E10) (mE10) |
Synonyms | CLAP CIPER |
Description | FUNCTION: Plays a key role in both adaptive and innate immune signaling by bridging CARD domain-containing proteins to immune activation . Acts by channeling adaptive and innate immune signaling downstream of CARD domain-containing proteins CARD9, CARD11 and CARD14 to activate NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines . Recruited by activated CARD domain-containing proteins: homooligomerized CARD domain-containing proteins form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10, subsequent recruitment of MALT1 and formation of a CBM complex . This leads to activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines . Activated by CARD9 downstream of C-type lectin receptors; CARD9-mediated signals are essential for antifungal immunity . Activated by CARD11 downstream of T-cell receptor (TCR) and B-cell receptor (BCR) . Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK . . |
Accessions | O95999 A2TDT2 ENST00000648566.1 ENST00000649060.1 A0A3B3ISX2 A0A087WWW9 ENST00000620248.3 |